Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis

被引:0
|
作者
Cai Miaotian [1 ,2 ,3 ]
Zhu Min [1 ,2 ]
Ban Chengjun [1 ,2 ]
Su Jin [1 ,2 ]
Ye Qiao [1 ,2 ]
Liu Yan [1 ,2 ]
Zhao Wen [1 ,2 ]
Wang Chen [2 ,4 ]
Dai Huaping [1 ,2 ]
机构
[1] Department of Respiratory and Critical Care Medicine,Beijing Chao-Yang Hospital,Capital Medical University
[2] Beijing Key Laboratory of Respiratory and Pulmonary Circulation,Beijing Institute of Respiratory Medicine
[3] Beijing Youan Hospital,Capital Medical University
[4] Beijing Hospital,National Clinical Research Center for Respiratory Medicine
基金
国科技部“十一五”科技计划项目;
关键词
D O I
暂无
中图分类号
R563 [肺疾病];
学科分类号
1002 ; 100201 ;
摘要
Background Idiopathic pulmonary fibrosis(IPF) is a lethal chronic interstitial lung disease(ILD) of unknown cause and having a variable and unpredictable course. This study aimed to summarize the clinical features and follow-up outcomes and to identify potential factors useful for the assessment of prognosis in IPF.Methods Two hundred and ten patients hospitalized and diagnosed as IPF in our unit from January 1999 to June 2007 were enrolled into this study. The baseline demographic, clinical, radiologic and physiologic characteristics were summarized. Clinical follow-up data until February 2010 were collected, and the median survival time and 1-, 2-, and 5-year survival rates, as well as the influences of the summarized baseline variables on the prognosis were analyzed.Results The age at diagnosis as IPF was(64±10) years, the duration before diagnosis of 106 patients(50%) was shorter than 2 years, and 73% were males. One hundred and forty-five patients(69%) had a history of smoking with a median pack-year of 18. Eighty-nine patients(42%) had emphysema and 62 patients(29%) pulmonary arterial hypertension(PAH). One hundred and twenty-four patients were followed up, of which 99 patients died from various causes including respiratory failure related to IPF(93%). The follow-up period was(21±23) months. The median survival time was 38 months. The 1-, 2-, and 5-year survival rates were 61%, 52%, and 39%, respectively. Multivariate analysis showed clubbing, PAH, duration from initial onset to diagnosis, and forced expiratory volume in 1 second(FEV1)/forced vital capacity(FVC) were independent prognostic indicators of IPF. Conclusion IPF patients who have clubbing, PAH, a higher FEV1/FVC, and a short duration from initial onset to diagnosis have a poorer outcome.
引用
收藏
页码:1868 / 1873
相关论文
共 50 条
  • [41] Comparison of clinical characteristics and prognosis in patients with idiopathic pulmonary upper lobe predominant pulmonary fibrosis and idiopathic pulmonary fibrosis
    Ohkubo, Hirotsugu
    Fukumitsu, Kensuke
    Fukuda, Satoshi
    Kanemitsu, Yoshihiro
    Takemura, Masaya
    Maeno, Ken
    Ito, Yutaka
    Niimi, Akio
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [42] CLINICAL EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Yamauchi, H.
    Bando, M.
    Sata, M.
    Nakasone, E.
    Mizushina, Y.
    Suzuki, E.
    Mato, N.
    Nakaya, T.
    Yamasawa, H.
    Sugiyama, Y.
    RESPIROLOGY, 2011, 16 : 318 - 319
  • [43] Clinical Characteristics Of Patients With Advanced Idiopathic Pulmonary Fibrosis
    de Andrade, J. A.
    Whelan, T.
    Luckhardt, T.
    Lancaster, L. H.
    Gamerman, V.
    Kulkarni, T.
    Neely, M. L.
    Yow, E.
    O'Brien, E.
    Conoscenti, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [44] Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis
    Callahan, Sean J.
    Xia, Meng
    Murray, Susan
    Flaherty, Kevin R.
    RESPIRATORY MEDICINE, 2016, 119 : 96 - 101
  • [45] Sonographic features of idiopathic pulmonary fibrosis
    Mansour, Osama F.
    Agha, Mohammed A.
    Al-Asdody, Ahmed A.
    Mehana, Naglaa S.
    Habib, Rehab M.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2018, 67 (01): : 50 - 55
  • [46] A comparison of clinical features between patients with idiopathic pulmonary fibrosis combined with emphysema and without emphysema
    马江伟
    China Medical Abstracts(Internal Medicine), 2013, 30 (02) : 94 - 94
  • [47] Outcomes in Patients Receiving Nintedanib or Pirfenidone for Idiopathic Pulmonary Fibrosis
    Cottin, V.
    Spagnolo, P.
    Bonniaud, P.
    Nolin, M.
    Dalon, F.
    Kirchgassler, K.
    Chia, J.
    Kamath, T. V.
    Van Ganse, E.
    Belhassen, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [48] Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes
    Akira Iyoda
    Yoko Azuma
    Susumu Sakamoto
    Sakae Homma
    Atsushi Sano
    Surgery Today, 2022, 52 : 736 - 744
  • [49] Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
    Yan, Wei
    Peng, Li-Ying
    Ban, Cheng-Jun
    Xu, Xue-Feng
    Zhu, Min
    Liu, Yan
    Zhang, Shu
    Zhai, Zhen-Guo
    Wang, Chen
    Dai, Hua-Ping
    CHINESE MEDICAL JOURNAL, 2015, 128 (07) : 896 - 901
  • [50] Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
    Yan Wei
    Peng Li-Ying
    Ban Cheng-Jun
    Xu Xue-Feng
    Zhu Min
    Liu Yan
    Zhang Shu
    Zhai Zhen-Guo
    Wang Chen
    Dai Hua-Ping
    中华医学杂志英文版, 2015, 128 (07) : 896 - 901